Conclusion: In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection (44%), hospitalization (56%), and mortality (68%) rates.
data from a prospective, observational study of the citywide COVID-19 prevention with ivermectin program, which was conducted between July 2020 and December 2020
peer-reviewed, published Jan 15, 2022
surprise motherfucker